Synonyms Complex dyslipidemia, Complex dyslipidemia (disorder), mixed dyslipidaemia + [1] |
Introduction- |
Target |
Mechanism PCSK9 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date08 Jan 2025 |
Target |
Mechanism PCSK9 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date09 Oct 2024 |
Target |
Mechanism PCSK9 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date26 Sep 2024 |
Start Date06 Jan 2025 |
Sponsor / Collaborator |
Start Date16 Oct 2024 |
Sponsor / Collaborator |
Start Date30 Sep 2024 |
Sponsor / Collaborator |